دورية أكاديمية
1442P DURATION: A multicenter randomized phase II trial investigating sequential mono- (mCTX) or doublet-chemotherapy (dCTX) followed by durvalumab (D) in older or frail patients with advanced non-small cell lung cancer (NSCLC)
| العنوان: | 1442P DURATION: A multicenter randomized phase II trial investigating sequential mono- (mCTX) or doublet-chemotherapy (dCTX) followed by durvalumab (D) in older or frail patients with advanced non-small cell lung cancer (NSCLC) |
|---|---|
| المؤلفون: | Kuon, J.B., Blasi, M., Kokowski, K., Faehling, M., Schuette, W., Christoph, D.C.C., Kimmich, M., Engel-Riedel, W., Fischer, J.R., Lehmann, M., Ulmer, M., Schuett, P., Moosmann, N., Meyer zum Büschenfelde, C., Griesinger, F., Schneider, M., Behnisch, R., Stenzinger, A., Christopoulos, P., Thomas, M. |
| المصدر: | Annals of Oncology ; volume 34, page S820 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2023.09.2473 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2023.09.2473Test https://api.elsevier.com/content/article/PII:S0923753423033100?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753423033100?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.B51805C5 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2023.09.2473 |
|---|